Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary Syndrome

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2200 participants.

Also called NCT07684742

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 2,200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07684742
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07684742. Randomized; no masking; primary purpose treatment. Start 2026-07-01 (actual); primary completion 2031-07-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary Syndrome
Acronym
SAPT-ACS
Condition
Acute Coronary Syndromes
Condition
STEMI
Condition
NSTEMI
Condition
Unstable Angina
Intervention (Drug)
Early P2Y12 Inhibitor Monotherapy
Intervention (Drug)
Standard Dual Antiplatelet Therapy
Lead sponsor
Gyeongsang National University Hospital (class: other)
Collaborator
Genoss Co., Ltd. (class: industry)
Collaborator
CGBio Inc. (class: industry)
Collaborator
Osstem vascular (class: not stated)
Collaborator
Dio (class: industry)

Record details

Record id
cardio:ct-nct07684742
Content hash
a50802de7830a1e22df14f30fea0cefe44bb12fbe0a884b140ee0d79618641c1